Rafferty Asset Management, LLC Athersys, Inc Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$1.41 - $1.94 $866,828 - $1.19 Million	-614,772 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$1.61 - $2.77 $846,256 - $1.46 Million	525,625 Added 589.62%	614,772 $1.11 Million
Q4 2020 Feb 10, 2021	SELL	$1.55 - $2.24 $389,566 - $562,985	-251,333 Reduced 73.82%	89,147 $156,000
Q3 2020 Nov 13, 2020	BUY	$1.91 - $3.08 $363,610 - $586,345	190,372 Added 126.82%	340,480 $664,000
Q2 2020 Aug 07, 2020	BUY	$1.97 - $3.98 $295,712 - $597,429	150,108 New	150,108 $414,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.